Preclinical studies further support these clinical findings, highlighting additional benefits of ghrelin, including the modulation of the autonomic nervous system, the promotion of vasodilation, the enhancement of endothelial function, the prevention of myocardial remodeling, the reduction in arrhythmogenic risk, and increased muscle mass in HF models. This evidence concerns the gene GHRL and hydrops fetalis.